Hostname: page-component-669899f699-ggqkh Total loading time: 0 Render date: 2025-04-25T11:09:46.373Z Has data issue: false hasContentIssue false

Incidence, pathophysiology, and treatment of failing Fontan after the total cavopulmonary connection

Published online by Cambridge University Press:  03 October 2024

Paula Gaebert
Affiliation:
Department of Congenital and Pediatric Heart Surgery, Technische Universität München, German Heart Center Munich, Munich, Germany Division of Congenital and Pediatric Heart Surgery, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany Europäisches Kinderherzzentrum München, Munich, Germany
Thibault Schaeffer
Affiliation:
Department of Congenital and Pediatric Heart Surgery, Technische Universität München, German Heart Center Munich, Munich, Germany Division of Congenital and Pediatric Heart Surgery, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany Europäisches Kinderherzzentrum München, Munich, Germany
Jonas Palm
Affiliation:
Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich at the Technical University of Munich, Munich, Germany
Chiara Di Padua
Affiliation:
Department of Congenital and Pediatric Heart Surgery, Technische Universität München, German Heart Center Munich, Munich, Germany Division of Congenital and Pediatric Heart Surgery, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany Europäisches Kinderherzzentrum München, Munich, Germany
Carolin Niedermaier
Affiliation:
Department of Congenital and Pediatric Heart Surgery, Technische Universität München, German Heart Center Munich, Munich, Germany Division of Congenital and Pediatric Heart Surgery, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany Europäisches Kinderherzzentrum München, Munich, Germany
Nicole Piber
Affiliation:
Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany
Alfred Hager
Affiliation:
Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich at the Technical University of Munich, Munich, Germany
Peter Ewert
Affiliation:
Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich at the Technical University of Munich, Munich, Germany
Jürgen Hörer
Affiliation:
Department of Congenital and Pediatric Heart Surgery, Technische Universität München, German Heart Center Munich, Munich, Germany Division of Congenital and Pediatric Heart Surgery, University Hospital of Munich, Ludwig-Maximilians-Universität, Munich, Germany Europäisches Kinderherzzentrum München, Munich, Germany
Masamichi Ono*
Affiliation:
Department of Congenital and Pediatric Heart Surgery, Technische Universität München, German Heart Center Munich, Munich, Germany
*
Corresponding author: Masamichi Ono; Email: [email protected]

Abstract

Background:

Failing Fontan poses a significant clinical challenge. This study aims to improve patients’ outcomes by comprehensively understanding the incidence, pathophysiology, risk factors, and treatment of failing Fontan after total cavopulmonary connection.

Methods:

We performed a retrospective analysis of patients who underwent total cavopulmonary connection at the German Heart Center Munich between 1994 and 2022. The onset of failing Fontan was defined as: protein-losing enteropathy, plastic bronchitis, NYHA class IV, NYHA class III for > one year, unscheduled hospital admissions for heart failure symptoms, and evaluation for heart transplantation.

Results:

Among 634 patients, 76 patients presented with failing Fontan, and the incidence was 1.48 per 100 patient-years. Manifestations included protein-losing enteropathy (n = 34), hospital readmission (n = 28), NYHA III (n = 18), plastic bronchitis (n = 16), evaluation for heart transplantation (n = 14), and NYHA IV (n = 4). Risk factors for the onset of failing Fontan were dominant right ventricle (p = 0.010) and higher pulmonary artery pressure before total cavopulmonary connection (p = 0.004). A total of 72 interventions were performed in 59 patients, including balloon dilatation/stent implantation in the total cavopulmonary connection pathway (n = 49) and embolization of collaterals (n = 24). Heart transplantation was performed in four patients. The survival after the onset of Fontan failure was 77% at 10 years. Patients with failing Fontan revealed significantly higher zlog-NT-proBNP levels after onset compared to those without (p = 0.021)

Conclusions:

The incidence of Fontan failure was 1.5 per 100 patient years. Dominant right ventricle and higher pulmonary artery pressure before total cavopulmonary connection were significant risks for the onset of failing Fontan. Zlog-NT-proBNP is only a late marker of Fontan failure.

Type
Original Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Paula Gaebert and Thibault Schaeffer contributed equally.

Meeting presentation: Presented at the 60th Annual Meeting of the Society of Thoracic Surgeons, San Antonio, Texas, January 27-29, 2024.

References

d’Udekem, Y, Iyengar, AJ, Galati, JC et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation 2014; 130: S32S38.CrossRefGoogle Scholar
Pundi, KN, Johnson, JN, Dearani, JA Li Z et al. 40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients. J Am Coll Cardiol 2015; 66: 17001710.CrossRefGoogle ScholarPubMed
Gewillig, M, Brown, SC, van de Bruaene, A, Rychik, J. Providing a framework of principles for conceptualising the Fontan circulation. Acta Paediatr 2020; 109: 651658.CrossRefGoogle ScholarPubMed
Goldberg, DJ, Shaddy, RE, Ravishankar, C, Rychik, J. The failing Fontan: etiology, diagnosis and management. Expert Rev Cardiovasc Ther 2011; 9(6): 785793.CrossRefGoogle ScholarPubMed
Ghanayem, NS, Berger, S, Tweddell, JS. Medical management of the failing Fontan. Pediatr Cardiol 2007; 28(6): 465471.CrossRefGoogle ScholarPubMed
Dennis, M, Zannino, D, du Plessis, K et al. Clinical outcomes in adolescents and adults after the Fontan procedure. J Am Coll Cardiol 2018; 71: 10091017.CrossRefGoogle ScholarPubMed
Book, WM, Gerardin, J, Saraf, A, Valente, AM, Rodriquez, F. Clinical phenotypes of Fontan failure: implications for management. Congenit Heart Dis 2016; 11: 296308.CrossRefGoogle ScholarPubMed
Gierlinger, G, Sames-Dolzer, E, Kreuzer, M et al. Surgical and interventional rescue strategies for Fontan failure. Interact Cardiovasc Thorac Surg 2022; 35(3): ivac098.CrossRefGoogle ScholarPubMed
van Melle, JP, Wolff, D, Hörer, J et al. Surgical options after Fontan failure. Heart 2016; 102: 11271133.CrossRefGoogle ScholarPubMed
Schilling, C, Dalziel, K, Nunn, R et al. The Fontan epidemic: population projections from the Australia and New Zealand Fontan registry. Int J Cardiol 2016; 219: 1419.CrossRefGoogle ScholarPubMed
Michielon, G, van Melle, JP, Wolff, D et al. Favourable mid-term outcome after heart transplantation for late Fontan failure. Eur J Cardiothorac Surg 2015; 47: 665671.CrossRefGoogle ScholarPubMed
Law, YM, Keller, BB, Feingold, BM, Boyle, GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 2005; 95: 474478.CrossRefGoogle ScholarPubMed
Lechner, E, Gitter, R, Mair, R et al. Aminoterminal brain natriuretic peptide levels in children and adolescents after Fontan operation correlate with congestive heart failure. Pediatr Cardiol 2008; 29(5): 901905.CrossRefGoogle ScholarPubMed
Schreiber, C, Hörer, J, Vogt, M, Cleuziou, J, Prodan, Z, Lange, R. Nonfenestrated extracardiac total cavopulmonary connection in 132 consecutive patients. Ann Thorac Surg 2007; 84: 894899.CrossRefGoogle ScholarPubMed
Ono, M, Kasnar-Samprec, J, Hager, A et al. Clinical outcome following total cavopulmonary connection: a 20-year single-centre experience. Eur J Cardiothorac Surg 2016; 50: 632641.CrossRefGoogle ScholarPubMed
Michel, SG, Menon, AK, Haas, NA, Hörer, J. Cavopulmonary support with a modified cannulation technique in a failing Fontan patient. Interact Cardiovasc Thorac Surg 2022; 35: ivac090.CrossRefGoogle Scholar
Kramer, P, Schleiger, A, Schafstedde, M et al. A multimodal score accurately classifies Fontan failure and late mortality in adult Fontan patients. Front Cardiovasc Med 2022; 9: 767503.CrossRefGoogle ScholarPubMed
Palm, J, Hoffmann, G, Klawonn, F et al. Continuous, complete and comparable NT-proBNP reference ranges in healthy children. Clin Chem Lab Med 2020; 58: 15091516.CrossRefGoogle ScholarPubMed
Hammer, V, Schaeffer, T, Staehler, H et al. Protein-losing enteropathy and plastic bronchitis following the total cavopulmonary connections. World J Pediatr Congenit Heart Surg 2023; 14: 691698.CrossRefGoogle ScholarPubMed
Hager, A. Invasive cardiopulmonary exercise testing in patients with Fontan circulation. J Am Coll Cardiol 2023; 81: 16011604.CrossRefGoogle ScholarPubMed
Miranda, WR, Borlaug, BA, Jain, CC et al. Exercise-induced changes in pulmonary artery wedge pressure in adults post-Fontan versus heart failure with preserved ejection fraction and non-cardiac dyspnoea. Eur J Heart Fail 2023; 25(1): 1725.CrossRefGoogle ScholarPubMed
Kamsheh, AM, O’Connor, MJ, Rossano, JW. Management of circulatory failure after Fontan surgery. Front Pediatr 2022; 10: 1020984.CrossRefGoogle ScholarPubMed
Dori, Y, Keller, MS, Rome, JJ et al. Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease. Circulation 2016; 133(12): 11601170.CrossRefGoogle ScholarPubMed
Smith, CL, Dori, Y, O’Byrne, ML, Glatz, AC, Gillespie, MJ, Rome, JJ. Transcatheter thoracic duct decompression for multicompartment lymphatic failure after Fontan palliation. Circ Cardiovasc Interv 2022; 15: e011733.CrossRefGoogle ScholarPubMed
Staehler, H, Schaeffer, T, Georgiev, S et al. Relationship of aortopulmonary collaterals and pulmonary artery development during staged single ventricle reconstruction. Pediatr Cardiol 2024. DOI: 10.1007/s00246-024-03484-y CrossRefGoogle ScholarPubMed
Kido, T, Stern, C, Heinisch, PP et al. The impact of pulmonary artery size on midterm outcomes after nonfenestrated Fontan operation. J Thorac Cardiovasc Surg 2023; 165: 16511660.CrossRefGoogle ScholarPubMed
Cindik, N, Gökdemir, M, Varan, B, Ulubay, G, Ozkan, M, Tokel, NK. Comparison of serum N-terminal pro-brain natriuretic peptide levels, conventional echocardiography, exercise parameters, and dyssynchrony measurements in Fontan patients. Cardiol Young 2023; 33: 17061712.CrossRefGoogle ScholarPubMed
Lin, HC, Huang, SC, Wu, MH et al. Preoperative N-terminal pro-brain natriuretic peptide is associated with Fontan outcomes. J Thorac Cardiovasc Surg 2022; 164: 770780.CrossRefGoogle ScholarPubMed
Bambul Heck, P, Muller, J, Weber, R, Hager, A. Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation. Eur J Heart Fail 2013; 15(6): 644649.CrossRefGoogle Scholar
Supplementary material: File

Gaebert et al. supplementary material

Gaebert et al. supplementary material
Download Gaebert et al. supplementary material(File)
File 23.9 KB